Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
3.
Prostate Cancer Prostatic Dis ; 18(2): 173-81, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25849354

RESUMEN

BACKGROUND: Medicare reimbursement cuts have been associated with declining gonadotropin-releasing hormone (GnRH) agonist overuse in localized prostate cancer. Medical school affiliation and foreign training have been associated with persistent overuse. However, physician-level prescribing changes and the practice type of persistent overusers have not been examined. We sought to describe physician-level changes in GnRH agonist overuse and test the association of time in practice and solo practice type with GnRH agonist overuse. METHODS: We matched American Medical Association physician data for 2138 urologists to Surveillance, Epidemiology and End Result-Medicare data for 12,943 men diagnosed with early-stage and lower-grade adenocarcinoma of the prostate between 2000 and 2007. We conducted a population-based, retrospective study using multilevel modeling to control for patient and provider characteristics. RESULTS: Three distinct patterns of GnRH agonist overuse were observed. Urologists' time in practice was not associated with GnRH agonist overuse (odds ratio (OR) 0.89; 95% confidence interval (CI): 0.75-1.05). However, solo practice type (OR 1.65; 95% CI: 1.34-2.02), medical school affiliation (OR 0.65; 95% CI: 0.55-0.77) and patient race were. Compared with non-Hispanic whites, non-Hispanic blacks (OR 1.76; 95% CI: 1.37-2.27), Hispanics (OR 1.41; 95% CI: 1.12-1.79) and men of 'other' race (OR 1.44; 95% CI: 1.04-1.99) had greater odds of receiving unnecessary GnRH agonists. CONCLUSIONS: GnRH agonist overuse remains high among some urologists who may be professionally isolated and difficult to reach. These urologists treat more vulnerable populations, which may contribute to health disparities in prostate cancer treatment quality. Nonetheless, these findings provide guidance to develop interventions to address overuse in prostate cancer.


Asunto(s)
Hormona Liberadora de Gonadotropina/uso terapéutico , Uso Excesivo de Medicamentos Recetados , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/epidemiología , Anciano , Hormona Liberadora de Gonadotropina/agonistas , Humanos , Masculino , Medicare , Médicos , Pautas de la Práctica en Medicina , Próstata/patología , Neoplasias de la Próstata/patología , Estudios Retrospectivos , Programa de VERF , Estados Unidos
4.
Acad Emerg Med ; 3(7): 694-9, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8816186

RESUMEN

OBJECTIVE: To characterize the ED utilization patterns of the elderly population using nationally representative data. METHODS: A secondary analysis was performed using the National Hospital Ambulatory Medical Care Survey (NHAMCS), a nationwide, stratified probability sample of ED encounters. Using these physician-reported data, the demographics, patient complaints, physician diagnoses, and dispositions were compared by age group, i.e., young-old (age 65-84 years) vs old-old (age > or = 85 years). RESULTS: The elderly (age > or = 65 years) represented 5,038 (19.6%) of 25,646 ED encounters for all adults (age > or = 18 years). The geriatric age groups (ages 65-74, 75-84, and > or = 85 years) accounted for 45.3%, 37.4%, and 17.2% of all the encounters by the elderly. The proportions of female patients and white patients were higher with increasing age. The proportion of elderly patients hospitalized was 4 times that of younger adults and reflected monotonic increase with increasing age among elders. Patient complaints and physician diagnoses were generally similar for the young-old (65-84 years) and the old-old (> or = 85 years). CONCLUSIONS: These findings are consistent with previous single-center studies of geriatric ED patients. This data source may be useful for investigation of clinical issues related to the care of elderly ED patients.


Asunto(s)
Atención Ambulatoria/estadística & datos numéricos , Servicio de Urgencia en Hospital/estadística & datos numéricos , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Recolección de Datos , Femenino , Humanos , Incidencia , Masculino , Estados Unidos
6.
Res Q Exerc Sport ; 63(2): 162-70, 1992 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-1585063

RESUMEN

The main purpose of the following experiments was to reexamine the acquisition effects of alternating actual and imagery practice on retention. This was accomplished by making retention comparisons between groups that either alternated actual and imagery practice, alternated actual practice and rest, employed all actual or all imagery practice, or performed an unrelated task (the control) during acquisition. Results from Experiment 1 indicated that the actual practice and the alternating actual and imagery practice groups produced equivalent scores that were greater than the equivalent scores of the imagery practice and alternating actual practice and rest groups. All experimental groups performed better than the control. Because the retention test was identical to the actual practice protocol, practice specificity may have biased the retention relative standings in favor of the actual practice group. Experiment 2 was identical to Experiment 1 except subjects were transferred to a contralateral limb retention test. Results indicated that the alternating actual and imagery practice group produced better retention scores than the equivalent retention scores of the actual practice and imagery practice groups. These three groups produced higher retention scores than the alternating actual practice and rest group, which was better than the control. These results support the notion that alternating actual and imagery practice facilitates motor learning and suggest that practice specificity may be a factor in response imagery experiments. Based on the notion that actual and imagery practice activate shared and unique mechanisms, several hypotheses were offered to explain these results.


Asunto(s)
Imaginación , Aprendizaje , Destreza Motora , Práctica Psicológica , Adulto , Femenino , Humanos , Masculino , Retención en Psicología
7.
J Oral Pathol Med ; 27(3): 101-5, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9563800

RESUMEN

Progression factors for periodontal diseases have been suggested by in vitro study of peripheral blood and gingival cells; however, those factors are not established in vivo. This investigation assessed biopsies of three groups of gingival tissues: those adjacent to a 1) < or =3 mm (normal), 2) 4-6 mm, and 3) >6 mm gingival sulcus, to determine changes in the gingival microenvironment coincident to the progression of periodontal disease. Superoxide dismutase (SOD) and catalase activity, and IL-12 and bcl-2 levels, were decreased at >6 mm; total protein and IL-6 concentrations were increased adjacent to >6 mm, as compared to < or =3 and 4-6 mm, sites. Apoptotic cells were evident only within gingiva adjacent to >6 mm sites. These data suggest that IL-12 is an important factor in the shift from a TH1 to TH2 cell profile and that a favorable gingival microenvironment for hyperinflammation may develop coincident to progression of periodontal diseases due to decreased bcl-2 and increased IL-6 concentrations within gingiva. These changes in the gingival microenvironment could impair apoptosis and promote enhanced release of reactive oxygen species (ROS) by phagocytes; decreased catalase and SOD activity could promote accumulation of ROS and result in additional tissue destruction.


Asunto(s)
Encía/fisiopatología , Enfermedades Periodontales/fisiopatología , Análisis de Varianza , Apoptosis , Catalasa/análisis , Progresión de la Enfermedad , Encía/enzimología , Encía/inmunología , Encía/metabolismo , Encía/patología , Hemorragia Gingival/patología , Hemorragia Gingival/fisiopatología , Gingivitis/patología , Humanos , Interleucina-12/análisis , Interleucina-6/análisis , Modelos Lineales , Enfermedades Periodontales/enzimología , Enfermedades Periodontales/inmunología , Enfermedades Periodontales/metabolismo , Enfermedades Periodontales/patología , Fagocitos/patología , Proteínas/análisis , Proteínas Proto-Oncogénicas c-bcl-2/análisis , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/análisis , Células TH1/patología , Células Th2/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA